EGFR and cancer: The depletion of alveolar macrophages may indeed increase the availability of RBCEVs, thus improving the efficiency of EGFR‐VHH‐coated immRNA‐loaded RBCEVs to target EGFR‐positive cancer cells in the lung parenchyma.